Filing metadata

Accession number
0001104659-23-008854
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Jan 31, 2023
Reporting period
Jan 29, 2023
Description
Insider transaction

Explore SEC Filings Hub